Yonggang Cui

发表

Peptide-based nanoprobes for molecular imaging and disease diagnostics.

Caleb F. Anderson, H. Cui, Rongfu Wang, 2018, Chemical Society reviews.

Design, synthesis and iodination of an Arg- Arg-Leu peptide for potential use as an imaging agent for human prostate carcinoma

Rongfu Wang, P. Yan, Yonggang Cui, 2008 .

2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma

Xueqi Chen, Caixia Wu, Yonggang Cui, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Theranostic supramolecular polymers formed by the self-assembly of a metal-chelating prodrug.

Weijie Zhang, Feihu Wang, H. Cui, 2020, Biomaterials science.

18F-FDG muscular superscan associated with lipid storage myopathy

Xueqi Chen, Yonggang Cui, Z. Fu, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients

Xueqi Chen, Rongfu Wang, Yonggang Cui, 2020, Nuclear medicine communications.

Noninvasive Visualization of RNA Delivery with 99mTc-Radiolabeled Small-Interference RNA in Tumor Xenografts

Rongfu Wang, P. Yan, L. Kang, 2010, Journal of Nuclear Medicine.

Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[18F]FDG PET/CT

Y. Xiong, Qun He, Caixia Wu, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative 18F-FDG PET/CT predicts poor prognosis of patients with clear cell renal cell carcinoma after nephrectomy.

Xueqi Chen, Rongfu Wang, L. Yin, 2020, European journal of radiology.

Molecular imaging and pharmacokinetics of (99m) Tc-hTERT antisense oligonucleotide as a potential tumor imaging probe.

Rongfu Wang, P. Yan, Yonggang Cui, 2014, Journal of labelled compounds & radiopharmaceuticals.